SGLT2 inhibitors and GLP1-receptor agonists reduce CHD risk in diabetes patients: Study Medha Baranwal22 March 2021 3:15 AM ISTItaly: Both SGLT2 inhibitors and GLP1-receptor agonists reduce the 10-year risk for cardiovascular disease in type 2 diabetes (T2D) patients without...
Ultrasound guided management of women with Gestational diabetes improves neonatal outcomes MD Bureau18 Feb 2021 7:00 PM ISTDuring the last couple of years, Ultrasound (US) based monitoring of fetal growth has become more relevant for optimizing treatment of pregnancies...
Low grade inflammation with high blood sugar increases death risk Medha Baranwal2 Feb 2021 10:18 PM ISTChina: Serum hs-CRP can predict 10-year all-cause mortality in Chinese adults with hyperglycemia, according to a recent study in the journal Diabetes...
Vitamin K2 supplementation lowers risk in Type 2 Diabetes Mellitus: Review Meghna A Singhania2 Jan 2021 12:45 PM ISTStudies on Vitamin K2 have witnessed a boom in the last few years owing to its multitude of beneficial effect on cardiovascular risk and vascular...
DPP-4 inhibitors and SGLT2 inhibitors effective in diabetics after kidney transplant Medha Baranwal26 Dec 2020 12:30 PM ISTGreece:Evidence regarding the utilization of DPP-4 inhibitors and particularly SGLT2 inhibitors and GLP-1 receptor agonists is limited in renal...
Covid 19 Infection led to ketoacidosis in diabetes patient: case report Dr. Kamal Kant Kohli14 May 2020 4:45 PM ISTPeople with diabetes are among those high risk categories that can have serious illness if they get infected with Covid 19 virus. The most...
